Seòmar agus comataidhean

The Scottish Government provided an evidence paper to the Education, Children and Young People Committee ahead of its meeting on 25 May 2022. This paper covers many of the issues subsequently raised in the written evidence submitted by the Scottish Private Nursery Association (SPNA) for that session.

The SPNA separately shared their written evidence with Scottish Government officials directly. Officials provided a detailed response to the SPNA on 3 August 2022. I would be happy to share this, and would invite the member to contact my office to request a copy.

Regular engagement with the childcare sector is a vital part of the Scottish Government’s approach to policy development and monitoring delivery of the 1140 expansion, and I am grateful to the SPNA for sharing their members’ concerns.

The Scottish Government has had very constructive discussions with AstraZeneca on Evusheld ® for the preventative treatments for COVID-19. However, throughout the pandemic, a UK-wide approach to the procurement of therapeutics has been taken and has proven vital to allow the UK to have the buying power to secure significant numbers of therapeutics in a competitive global market. A UK-wide approach has also been taken on the development and implementation of clinical prescribing policies for COVID-19 therapeutics. This has ensured patients across the UK have had equal access to safe and effective medicines for COVID-19.

The Lyme disease vaccine candidate VLA15 was developed in Austria and, as such, is not directly supported by Scottish funding. The Scottish Government is however regarded as preferred customers for Valneva, and should the decision be taken to procure Lyme Disease vaccines from Valneva, the Scottish Government will receive preferential access and pricing. This is in recognition of the support provided to Valneva by Scotland.

Scottish Enterprise have supported Valneva Livingston with funding packages for the following vaccines, all of which have received grant support:

• Japanese Encephalitis
• Zika
• Chikungya
• Covid-19

I have a weekly portfolio meeting, usually held on a Monday, with officials and clinical advisers, including the Chief Medical Officer, during which any updates regarding the monkeypox outbreak in Scotland have been, and will continue to be, discussed.

As outlined in the answer to S6W-10089, the Cabinet Secretary for Health and Social Care attends regular meetings with his counterparts in the UK and other Devolved Administrations to ensure that the Scottish Government is represented in relation to public health incidents which require a coordinated 4 Nations response. The last meeting of the UK Health Ministers Forum was on 16 June 2022. The UK Health Ministers Forum has now been replaced by an Inter-Ministerial Group meeting which is expected to meet for the first time in mid-October.

Non-NHS provider figures relate to patients treated in non-NHS locations such as private hospitals, hospices, nursing homes, and care homes. Patients who receive treatment at a private (independent) hospital which is paid for by the NHS board should be recorded within the SMR by the relevant NHS board.

The following table presents the procedure information that has been supplied to Public Health Scotland (PHS).

Table 1: The number of procedures performed by Non-NHS Providers.

I refer the member to the answer to question S6W-10385 on 20 September 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Over the last two and a half years, our NHS has suffered the biggest shock of its 74-year existence. Caring for large numbers of patients seriously unwell with COVID-19 has inevitably meant that planned care procedures have had to be delayed, and while we are working hard to recover and remobilise our NHS, this will not be done in a few weeks or even months. Throughout the pandemic, NHS Boards have ensured that urgent, maternity and vital cancer services continue as usual. Addressing the backlog of care, while continuing to meet the ongoing urgent health and care needs of the country, remains a priority for this Government.

We recognise the impact long waiting times can have on patients. That is why we have introduced a new set of ambitious targets for NHS Scotland to address the backlog of planned care. Key targets are to eliminate:

• Two-year waits for outpatients in most specialities by the end of August 2022
• 18-month waits for outpatients in most specialities by the end of December 2022
• One-year waits for outpatients in most specialities by the end of March 2023
• Two-year waits for inpatient / daycases in most specialities by the end of September 2022
• 18-month waits for inpatient / daycases in most specialities by the end of September 2023
• One-year waits for inpatient / daycases in most specialities by the end of September 2024

We are working with NHS Boards to maximise capacity to meet these targets and have increased the flexibility Health Boards and clinicians have to manage waiting lists, with a focus on eliminating long waits, as well as continuing to treat the most clinically urgent patients.

The latest Private Healthcare Information Network figures show Scotland has lower rates of self-pay admissions per head of population than England and Wales

The Scottish Government is working with Local Authorities, COSLA and the wider public sector to ensure that there is sufficient suitable accommodation for Ukrainian Displaced Persons.

We intend to publish numbers on temporary accommodation in due course.

Following the first Oversight Group meeting in June, David Strang, former chair of the Drug Death Taskforce, has accepted my offer to become Chair of the group, ensuring its independence from government. I will of course continue to attend as a member of the group. This will begin from the next meeting scheduled for 22 September 2022.

To ensure independence from government, a steering board of members has been nominated to co-ordinate the agenda for Oversight Group meetings.

Circularity Scotland Ltd is a private, not-for-profit business. As such, the Scottish Government does not have access to this information.